BIOMAT Database Logo BIOMAT Database Logo

Is there any place for salmon calcitonin in prevention of postmenopausal bone loss? 1988

J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Rheumatology and Physical Medicine Department, University of Liège, Belgium.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012474 Salmon Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed). Oncorhynchus gorbuscha,Oncorhynchus nerka,Oncorhynchus tshawytscha,Salmo salmo,Salmon, Chinook,Salmon, Pink,Salmon, Sockeye,Chinook Salmon,Pink Salmon,Sockeye Salmon

Related Publications

J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Calcitonin for prevention of postmenopausal bone loss.
April 1988, Lancet (London, England),
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Intranasal calcitonin and prevention of postmenopausal bone loss.
February 1988, Lancet (London, England),
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Calcitonin for postmenopausal bone loss.
June 1988, Lancet (London, England),
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Salmon calcitonin in the prevention of bone loss at perimenopause.
June 1996, Bone,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
April 1992, Calcified tissue international,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
September 1993, Minerva endocrinologica,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
July 1996, Calcified tissue international,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Kidney transplantation: is there any place for refugees?
May 2007, Transplantation proceedings,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
December 1993, Maturitas,
J Y Reginster, and R Deroisy, and D Denis, and M P Lecart, and N Sarlet, and P Franchimont
Is there any place for macrolides in mood disorders?
January 2012, Medical hypotheses,
Copied contents to your clipboard!